A total of 29 genes were associated with cancers, and 12 were associated with hematological disease, including the MTOR gene which is in the Akt/mTOR pathway and is critical for cell survival and proliferation in high-risk MDS patients [53]. Here, MTOR is linked to myelodysplastic syndrome.